Amgen's cholesterol drug lowered risk of cardiovascular trouble in a huge clinical trial — but the results may not be good enough for insurers to cover.
By Damian Garde, STAT
By PBS NewsHour
When Does Genetic Modification of Animals Cross a Line?…
In the latest in a series of reports making sense of the economy, economics correspondent Paul Solman examines the small scale of nanosciences and the big impact they could have on the economy.
A recent surge in investments by venture capitalists in eco-friendly businesses is possibly triggering a boom in green and clean technology. Analysts report on the green market and its ability to make money while saving oil.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.